Scientists test Triple-Threat attack on tough bladder cancers
NCT ID NCT05154994
Summary
This early-stage trial is testing the safety and best dose of a three-drug combination for patients with advanced bladder cancer that has spread or cannot be removed by surgery. The treatment combines two immunotherapy drugs that help the immune system fight cancer with a third drug that targets cancer cell growth. The study aims to see if this combination is safe and can help control the disease in patients whose cancer has worsened after prior treatments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC UROTHELIAL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Huntsman Cancer Institute/University of Utah
Salt Lake City, Utah, 84112, United States
Conditions
Explore the condition pages connected to this study.